Citation: Hc. Geiss et al., Parameters of childhood obesity and their relationship to cardiovascular risk factors in healthy prepubescent children, INT J OBES, 25(6), 2001, pp. 830-837
Citation: E. Ohrig et al., The Prevention Education Program (PEP) Nuremberg: design and baseline dataof a family oriented intervention study, INT J OBES, 25, 2001, pp. S89-S92
Authors:
Kromeyer-Hauschild, K
Wabitsch, M
Kunze, D
Geller, D
Geiss, HC
Hesse, V
von Hippel, A
Jaeger, U
Johnsen, D
Korte, W
Menner, K
Muller, G
Muller, JM
Niemann-Pilatus, A
Remer, T
Schaefer, F
Wittchen, HU
Zabransky, S
Zellner, K
Ziegler, A
Hebebrand, J
Citation: K. Kromeyer-hauschild et al., Percentiles of body mass index in children and adolescents evaluated from different regional German studies, MONATS KIND, 149(8), 2001, pp. 807-818
Authors:
Geiss, HC
Otto, C
Schwandt, P
Parhofer, KG
Citation: Hc. Geiss et al., Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects, METABOLISM, 50(8), 2001, pp. 983-988
Authors:
Frost, RJA
Otto, C
Geiss, HC
Schwandt, P
Parhofer, KG
Citation: Rja. Frost et al., Effects of Atorvastatin versus Fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters intype 2 diabetes mellitus with mixed hyperlipoproteinemia, AM J CARD, 87(1), 2001, pp. 44-48
Authors:
Schamberger, BM
Geiss, HC
Ritter, MM
Schwandt, P
Parhofer, KG
Citation: Bm. Schamberger et al., Influence of LDL apheresis on LDL subtypes in patients with coronary heartdisease and severe hyperlipoproteinemia, J LIPID RES, 41(5), 2000, pp. 727-733
Citation: Hc. Geiss et al., Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis, J INTERN M, 245(1), 1999, pp. 47-55
Authors:
Schwandt, P
Geiss, HC
Ritter, MM
Ublacker, C
Parhofer, KG
Otto, C
Laubach, E
Donner, MG
Haas, GM
Richter, WO
Citation: P. Schwandt et al., The prevention education program (PEP), a prospective study of the efficacy of family-oriented life style modification in the reduction of cardiovascular risk and disease: Design and baseline data, J CLIN EPID, 52(8), 1999, pp. 791-800